Glycosylation of pilin and nonpilin protein constructs by Pseudomonas aeruginosa 1244

Journal of Bacteriology

Volumn 192, Issue 22, 2010, Pages 5972-5981

  Qutyan, Mohammed ^a   Henkel, Matthew ^a   Horzempa, Joseph ^a,b   Quinn, Michael ^a   Castric, Peter ^a  

^a DUQUESNE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BACTERIAL PROTEIN; PILIN; PROTEIN PILO; SERINE; TRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PSEUDOMONAS AERUGINOSA; SITE DIRECTED MUTAGENESIS;

ALKALINE PHOSPHATASE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BACTERIAL PROTEINS; ESCHERICHIA COLI PROTEINS; FIMBRIAE PROTEINS; GLYCOSYLATION; HEXOSYLTRANSFERASES; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; PSEUDOMONAS AERUGINOSA; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY;

ESCHERICHIA COLI; HEDYOTIS MANNII; PSEUDOMONAS AERUGINOSA;

EID: 78049417390     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00007-10     Document Type: Article

References (52)

1. Aas, F. E., W. Egge-Jacobsen, H. C. Winther-Larsen, C. Lovold, P. G. Hitchen, A. Dell, and M. Koomey. 2006. Neisseria gonorrhoeae type IV pili undergo multisite hierarchical modifications with phosphoethanolamine and phosphocholine requiring an enzyme structurally related to lipopolysaccharide phosphoethanolamine transferases. J. Biol. Chem. 281:27712-27723.
2. Asikyan, M. L., J. V. Kus, and L. L. Burrows. 2008. Novel proteins that modulate type IV pilus retraction dynamics in Pseudomonas aeruginosa. J. Bacteriol. 190:7022-7034.
3. Bernard, C. S., C. Bordi, E. Termine, A. Filloux, and S. de Bentzmann. 2009. Organization and PprB-dependent control of the Pseudomonas aeruginosa tad locus, involved in Flp pilus biology. J. Bacteriol. 191:1961-1973.
4. Bolivar, F., and K. Backman. 1979. Plasmids of Escherichia coli as cloning vectors. Methods Enzymol. 68:245-267.
5. Borud, B., F. E. Aas, A. Vik, H. C. Winther-Larsen, W. Egge-Jacobsen, and M. Koomey. 2010. Genetic, structural, and antigenic analyses of glycan diversity in the O-linked protein glycosylation systems of human Neisseria species. J. Bacteriol. 192:2816-2829.
6. Castric, P. 1995. pilO, a gene required for glycosylation of Pseudomonas aeruginosa 1244 pilin. Microbiology 141:1247-1254.
7. Castric, P., F. J. Cassels, and R. W. Carlson. 2001. Structural characterization of the Pseudomonas aeruginosa 1244 pilin glycan. J. Biol. Chem. 276:26479-26485.
8. Castric, P. A., and C. D. Deal. 1994. Differentiation of Pseudomonas aeruginosa pili based on sequence and B-cell epitope analyses. Infect. Immun. 62:371-376.
9. Comer, J. E., M. A. Marshall, V. J. Blanch, C. D. Deal, and P. Castric. 2002. Identification of the Pseudomonas aeruginosa 1244 pilin glycosylation site. Infect. Immun. 70:2837-2845.
10. Comolli, J. C., A. R. Hauser, L. Waite, C. B. Whitchurch, J. S. Mattick, and J. N. Engel. 1999. Pseudomonas aeruginosa gene products PilT and PilU are required for cytotoxicity in vitro and virulence in a mouse model of acute pneumonia. Infect. Immun. 67:3625-3630.
11. Craig, L., M. E. Pique, and J. Tainer. 2004. Type IV pilus structure and bacterial pathogenicity. Nat. Rev. Microbiol. 2:363-378.
12. Daniels, C., C. Vindurampulle, and R. Morona. 1998. Overexpression and topology of the Shigella flexneri O-antigen polymerase (Rfc/Wzy). Mol. Microbiol. 28:1211-1222.
13. Dean, C. R., C. V. Franklund, J. D. Retief, M. J. Coyne, K. Hatano, D. Evans, G. B. Pier, and J. B. Goldberg. 1999. Characterization of the serogroup O11 O-antigen locus of Pseudomonas aeruginosa PA103. J. Bacteriol. 181:4275-4284.
14. DiGiandomenico, A., M. J. Matewish, A. Bisaillon, J. R. Stehle, J. S. Lam, and P. Castric. 2002. Glycosylation of Pseudomonas aeruginosa 1244 pilin: specificity of glycan substrate. Mol. Microbiol. 46:519-530.
15. DiGiandomenico, A., J. Rao, K. Archer, T. S. Saidi, J. Gardner, A. N. Neely, G. B. Pier, and J. B. Goldberg. 2007. Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections. Proc. Natl. Acad. Sci. U. S. A. 104:4624-4629.
16. Doring, G., and G. B. Pier. 2008. Vaccines and immunotherapy against Pseudomonas aeruginosa. Vaccine 26:1011-1024.
17. Englard, S., and S. Seifter. 1990. Precipitation techniques, p. 285-300. In M. P. Deutscher (ed.), Guide to protein purification, vol. 182. Academic Press, Inc., San Diego, CA.
18. Faridmoayer, A., M. A. Fentabil, M. F. Haurat, W. Yi, R. Woodward, P. G. Wang, and M. F. Feldman. 2008. Extreme substrate promiscuity of the Neisseria oligosaccharyl transferase involved in protein O-glycosylation. J. Biol. Chem. 283:34596-34604.
19. Feldman, M. F., C. L. Marolda, M. A. Monteiro, M. B. Perry, A. J. Parodi, and M. A. Valvano. 1999. The activity of a putative polyisopronol-linked sugar translocase (Wzx) involved in Escherichia coli O antigen assembly is independent of the chemical structure of the O repeat. J. Biol. Chem. 274:35129-35138.
20. Furste, J. P., W. Pansegrau, F. R. Blocker, P. Scholz, M. Bagdasarian, and E. Lanka. 1986. Molecular cloning of the plasmid RP4 primase region in a multi-host-range tacP expression vector. Gene 48:119-131.
21. Garen, A., and C. Levinthal. 1960. A fine structure genetic and chemical study of the enzyme alkaline phosphatase of Escherichia coli. Biochim. Biophys. Acta 38:470-483.
22. Guerry, P., and C. M. Szymanski. 2008. Campylobacter sugars sticking out. Trends Microbiol. 16:428-435.
23. Hansen, J. K., and K. T. Forest. 2006. Type IV pilin structures: insights on shared architecture, fiber assembly, receptor binding and type II secretion. J. Mol. Microbiol. Biotechnol. 11:192-207.
24. Hatano, K., and G. B. Pier. 1998. Complex serology and Immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains. Infect. Immun. 66:3719-3726.
25. Hazes, B., P. A. Sastry, K. Hayakawa, R. J. Read, and R. T. Irvin. 2000. Crystal structure of Pseudomonas aeruginosa PAK pilin suggests a main-chain-dominated mode of receptor binding. J. Mol. Biol. 299:1005-1017.
26. Heiniger, R. W., H. C. Winther-Larsen, R. J. Pickles, M. Koomey, and M. C. Wolfgang. 2010. Infection of human mucosal tissue by Pseudomonas aeruginosa requires sequential and mutually dependent virulence factors and novel pilus-associated adhesin. Cell. Microbiol. 12:1158-1173.
27. Horzempa, J., J. E. Comer, S. A. Davis, and P. Castric. 2006. Glycosylaton substrate specificity of Pseudomonas aeruginosa 1244 pilin. J. Biol. Chem. 281:1128-1136.
28. Horzempa, J., R. D. Dean, J. B. Goldberg, and P. Castric. 2006. Pseudomonas aeruginosa 1244 pilin glycosylation: glycan substrate recognition. J. Bacteriol. 188:4244-4252.
29. Horzempa, J., T. K. Held, A. S. Cross, D. Furst, M. Qutyan, A. N. Neely, and P. Castric. 2008. Immunization with a Pseudomonas aeruginosa 1244 pilin provides O-antigen-specific protection. Clin. Vaccine Immunol. 15:590-597.
30. Hunt, J. D., D. C. Jackson, L. E. Brown, P. R. Wood, and D. J. Stewart. 1994. Antigenic competition in a multivalent foot rot vaccine. Vaccine 12:457-464.
31. Kadokura, H., and J. Beckwith. 2009. Detecting folding intermediates of a protein as it passes through the bacterial translocation channel. Cell 138:1164-1173.
32. Kim, E. E., and H. W. Wyckoff. 1991. Reaction mechanism of alkaline phosphatase based on crystal structures. Two-metal ion catalysis. J. Mol. Biol. 218:449-464.
33. Kus, J. V., E. Tullis, D. G. Cvitkovitch, and L. L. Burrows. 2004. Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CF patients. Microbiology 150:1315-1326.
34. Liu, P. V. 1973. Exotoxins of Pseudomonas aeruginosa. I. Factors that influence the production of exotoxin A. J. Infect. Dis. 128:506-513.
35. Liu, P. V., H. Matsumoto, H. Kusama, and T. Bergan. 1983. Survey of heat-stable, major somatic antigens of Pseudomonas aeruginosa. Int. J. Syst. Bacteriol. 33:256-264.
36. Manoil, C. 1991. Analysis of membrane protein topology using alkaline phosphatase and beta-galactosidase gene fusions. Methods Cell Biol. 35:61-75.
37. Mattick, J. S. 2002. Type IV pili and twitching motility. Annu. Rev. Microbiol. 56:289-314.
38. Ohama, M., K. Hiramatsu, Y. Miyajima, K. Kishi, M. Nasu, and J. Kadota. 2006. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice. FEMS Immunol. Med. Microbiol. 47:107-115.
39. O'Toole, G. A., and R. Kolter. 1998. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30:295-304.
40. Pier, G. B., H. F. Sidberry, and J. C. Sadoff. 1978. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa. Infect. Immun. 22:919-925.
41. Poole, K., and R. A. Hancock. 1984. Phosphate transport in Pseudomonas aeruginosa. Involvement of a periplasmic phosphate-binding protein. Eur. J. Biochem. 144:607-612.
42. Qutyan, M., M. Paliotti, and P. Castric. 2007. PilO of Pseudomonas aeruginosa 1244: subcellular location and domain assignment. Mol. Microbiol. 66:1444-1458.
43. Ramphal, R., L. Koo, K. S. Ishimoto, P. A. Totten, J. C. Lara, and S. Lory. 1991. Adhesion of Pseudomonas aeruginosa pilin-deficient mutants to mucin. Infect. Immun. 59:1307-1311.
44. Ramphal, R., J. Sadoff, M. Pyle, and J. D. Silipigni. 1984. Role of pili in the adherence of Pseudomonas aeruginosa to injured tracheal epithelium. Infect. Immun. 44:38-40.
45. Ruer, S., S. Stender, A. Filloux, and S. de Bentzmann. 2007. Assembly of fimbrial structures in Pseudomonas aeruginosa: functionality and specificity of chaperone-usher machineries. J. Bacteriol. 189:3547-3555.
46. Sadoff, J. C., D. C. Wright, S. Futrovsky, H. Sidberry, H. Collins, and B. Kaufmann. 1985. Characterization of mouse monoclonal antibodies directed against Pseudomonas aeruginosa lipopolysaccharides. Antibiot. Chemother. 36:134-146.
47. Smedley, J. G., III, E. Jewell, J. Roguskie, J. Horzempa, A. Seyboldt, D. B. Stolz, and P. Castric. 2005. Influence of pilin glycosylation on Pseudomonas aeruginosa 1244 pilus function. J. Bacteriol. 73:7922-7931.
48. Szymanski, C. M., and B. W. Wren. 2005. Protein glycosylation in bacterial mucosal pathogens. Nat. Rev. Microbiol. 3:225-237.
49. Vik, A., F. E. Aas, J. H. Anonsen, S. Bisborough, A. Schneider, W. Egge-Jacobsen, and M. Koomey. 2009. Broad spectrum O-linked protein glycosylation in the human pathogen Neisseria gonorrhoeae. Proc. Natl. Acad. Sci. U. S. A. 106:4447-4452.
50. West, S. E. H., H. P. Schweizer, C. Dall, A. K. Sample, and L. J. Runyen-Janecky. 1994. Construction of improved Escherichia coli-Pseudomonas shuttle vectors derived from pUC18/19 and the sequence of the region required for their replication in Pseudomonas aeruginosa. Gene 128:81-86.
51. Wood, D. E., D. C. Strauss, W. G. Johanson, V. K. Berry, and J. A. Bass. 1980. Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infect. Immun. 29:1146-1151.
52. Zuercher, A. W., M. P. Horn, H. Wu, Z. Song, C. J. Bundgaard, H. K. Johansen, N. Hoiby, P. Marcus, and A. B. Lang. 2006. Intranasal immunization with conjugate vaccine protects mice from systemic and respiratory tract infection with Pseudomonas aeruginosa. Vaccine 24:4333-4342.